A group of researchers working in some prominent academic medical centers and hospitals, including Tel Aviv University, Hillel Yaffe Medical Center, and Samson Assuta Ashdod University Hospital, recently published their research in the peer-reviewed journal Clinical Microbiology and Infection. The team, represented by corresponding author Tal Brosh-Nissimov, uncovered significant challenges with patients vaccinated for COVID-19. Specifically, while acknowledging the overall positive impact of the vaccines, the investigators indicate a concern with not only breakthrough infections (that is, vaccinated individuals still getting infected with SARS-CoV-2) but also evidence for risks of hospitalization and even death associated with these cases.
The Study Goal
The group of researchers organized this retrospective, multicenter cohort study of 152 fully vaccinated patients hospitalized in 17 health centers across Israel. Vaccinated with Pfizer-BioNTech’s BNT162b2, the study included hospitalized patients who succumbed to SARS-SoV-2 infection seven days after the second jab. The researchers sought to better understand the risks to this class of patient.
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).